AP-2α functions as a novel tumor suppressor to inhibit the stemness of glioma cancer cells by inhibiting the Nanog/Sox2/CD133 regulatory axis and decreasing the resistance of glioma cells to TMZ by blocking the IL6/Jak2/STAT3 signaling pathway. This evidence concerns the gene STAT3 and central nervous system cancer.